Anasua Pal, PhD
Business Development Manager
Anasua is a seasoned professional in business development within the life sciences industry, with a strong focus on dermatology and immune-mediated diseases. She holds a PhD from the German Cancer Research Center (DKFZ) in Heidelberg, specializing in NK cells. Additionally, she has earned certifications in clinical trial study design and business development.
As a Business Development Manager at Symbio, Anasua plays a crucial role in expanding the company’s market presence across the APAC and EMEA regions. She specializes in identifying and cultivating key collaborations with pharmaceutical and biotech companies, aligning Symbio’s comprehensive CRO services with client needs to drive revenue growth and support therapeutic drug development.
With four years of experience in the preclinical and clinical research sectors, Anasua has built expertise in dermatology-focused business development. She has previously collaborated with pharmaceutical and biotech firms and has presented at prestigious conferences, including the Society of Investigative Dermatology (SID) Conference in Dallas (2024).
Her specialized training includes immunology, dermatology, B2B sales, and clinical trial analysis, making her a valuable asset in the field of drug development and clinical research partnerships.